News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
206,087 Results
Type
Article (19750)
Company Profile (39)
Press Release (186298)
Multimedia
Podcasts (10)
Webinars (3)
Section
Business (51206)
Career Advice (264)
Deals (7362)
Drug Delivery (31)
Drug Development (38897)
Employer Resources (21)
FDA (5964)
Job Trends (4902)
News (100535)
Policy (8083)
Tag
2024 BioCapital Digital (1)
2024 BioForest Digital (4)
2024 BioForest Standard (1)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (1)
2024 Biotech Bay Standard (2)
2024 Biotech Beach Digital (1)
2024 Genetown Standard (1)
2024 Lone Star Bio Digital (1)
2024 Pharm Country Standard (1)
2026 BioMidwest Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (1)
Academia (1485)
Accelerated approval (4)
Adcomms (13)
Allergies (40)
Alliances (14725)
ALS (49)
Alzheimer's disease (1167)
Antibody-drug conjugate (ADC) (101)
Approvals (5992)
Artificial intelligence (96)
Autoimmune disease (4)
Automation (2)
Bankruptcy (36)
Best Places to Work (4636)
Biosimilars (33)
Biotechnology (36)
Bladder cancer (48)
Brain cancer (31)
Breast cancer (209)
Cancer (1682)
Cardiovascular disease (51)
Career advice (232)
Career pathing (8)
CAR-T (86)
Cell therapy (236)
Cervical cancer (9)
Clinical research (30862)
Collaboration (404)
Compensation (100)
Complete response letters (11)
COVID-19 (763)
CRISPR (17)
C-suite (95)
Cystic fibrosis (53)
Data (1198)
Denatured (5)
Depression (26)
Diabetes (67)
Diagnostics (2095)
Digital health (5)
Diversity (2)
Diversity, equity & inclusion (6)
Drug discovery (51)
Drug pricing (12)
Drug shortages (2)
Duchenne muscular dystrophy (32)
Earnings (17933)
Editorial (13)
Employer branding (3)
Employer resources (21)
Events (32182)
Executive appointments (270)
FDA (6575)
Featured Employer (9)
Friedreich's ataxia (2)
Frontotemporal dementia (5)
Funding (340)
Gene editing (43)
Generative AI (7)
Gene therapy (147)
GLP-1 (194)
Government (1212)
Guidances (16)
Healthcare (7618)
Huntington's disease (15)
IgA nephropathy (11)
Immunology and inflammation (45)
Indications (16)
Infectious disease (808)
Inflammatory bowel disease (46)
Inflation Reduction Act (2)
Influenza (15)
Intellectual property (36)
Interviews (40)
IPO (4061)
IRA (7)
Job creations (493)
Job search strategy (198)
Kidney cancer (6)
Labor market (2)
Layoffs (128)
Leadership (6)
Legal (957)
Liver cancer (48)
Lung cancer (262)
Lymphoma (101)
Machine learning (2)
Management (9)
Manufacturing (69)
MASH (10)
Medical device (3128)
Medtech (3130)
Mergers & acquisitions (3482)
Metabolic disorders (161)
Multiple sclerosis (48)
NASH (2)
Neurodegenerative disease (62)
Neuropsychiatric disorders (6)
Neuroscience (1493)
NextGen: Class of 2025 (1953)
Non-profit (3003)
Northern California (1108)
Now hiring (1)
Obesity (89)
Opinion (68)
Ovarian cancer (66)
Pain (28)
Pancreatic cancer (60)
Parkinson's disease (109)
Partnered (9)
Patents (79)
Patient recruitment (56)
Peanut (24)
People (16366)
Pharmaceutical (6)
Phase I (11380)
Phase II (13426)
Phase III (9674)
Pipeline (594)
Policy (20)
Postmarket research (894)
Preclinical (4711)
Press Release (22)
Prostate cancer (61)
Psychedelics (10)
Radiopharmaceuticals (167)
Rare diseases (221)
Real estate (980)
Recruiting (4)
Regulatory (6839)
Reports (11)
Research institute (1370)
Resumes & cover letters (30)
Rett syndrome (3)
RNA editing (2)
RSV (16)
Schizophrenia (30)
Series A (60)
Series B (37)
Sickle cell disease (24)
Southern California (893)
Special edition (5)
Spinal muscular atrophy (112)
Sponsored (10)
Startups (1101)
State (1)
Stomach cancer (11)
Supply chain (10)
Tariffs (2)
The Weekly (5)
United States (8883)
Vaccines (264)
Venture capitalists (15)
Weight loss (39)
Women's health (5)
Worklife (4)
Date
Today (41)
Last 7 days (173)
Last 30 days (963)
Last 365 days (13634)
2025 (3856)
2024 (14500)
2023 (16676)
2022 (20467)
2021 (20799)
2020 (18130)
2019 (15527)
2018 (11559)
2017 (10681)
2016 (9930)
2015 (11170)
2014 (7552)
2013 (5799)
2012 (5779)
2011 (5805)
2010 (5057)
Location
Africa (162)
Alabama (9)
Alaska (2)
Arizona (33)
Arkansas (3)
Asia (13065)
Australia (1922)
California (2340)
Canada (627)
China (272)
Colorado (111)
Connecticut (120)
Delaware (68)
Europe (27158)
Florida (303)
Georgia (65)
Idaho (17)
Illinois (210)
India (4)
Indiana (109)
Iowa (4)
Japan (83)
Kansas (52)
Kentucky (17)
Maine (9)
Maryland (294)
Massachusetts (1891)
Michigan (39)
Minnesota (113)
Missouri (30)
Montana (11)
Nebraska (9)
Nevada (17)
New Hampshire (16)
New Jersey (711)
New Mexico (14)
New York (766)
North Carolina (324)
North Dakota (3)
Northern California (1108)
Ohio (66)
Oklahoma (5)
Oregon (12)
Pennsylvania (497)
Rhode Island (11)
South America (211)
South Carolina (3)
South Dakota (1)
Southern California (893)
Tennessee (14)
Texas (467)
Utah (51)
Virginia (61)
Washington D.C. (13)
Washington State (240)
West Virginia (1)
Wisconsin (14)
206,087 Results for "pediatric brain tumor foundation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Ursula Burns, former Xerox CEO, and Jordan Wertlieb, EVP and COO of Hearst, appointed to the Pediatric Brain Tumor Foundation’s Advisory Board as inaugural members
The Pediatric Brain Tumor Foundation announced the appointment of Ursula Burns and Jordan Wertlieb as inaugural members of the organization’s new Advisory Board.
June 25, 2024
·
5 min read
Press Releases
The Pediatric Brain Tumor Foundation welcomes Day One Biopharmaceuticals’ renowned Dr. Samuel C. Blackman to its Board of Directors
January 31, 2025
·
4 min read
Press Releases
U.S. Food and Drug Administration Approves FoundationOne®CDx as a Companion Diagnostic for OJEMDA™ (tovorafenib) to Treat the Most Common Form of Childhood Brain Tumor in Pediatric Patients
January 17, 2025
·
5 min read
Press Releases
CBTN Partners with Day One to Drive New Therapies for Pediatric Brain Tumors
December 17, 2024
·
2 min read
Press Releases
Treovir and Matica Bio Forms Strategic Partnership to Advance Innovative Therapies for Pediatric Brain Tumors
December 4, 2024
·
3 min read
FDA
PNOC Foundation, a Leading Non-profit to Further Advancements in Pediatric Brain Cancer, Announces FDA Approval of Tovorafenib (Day101) in Partnership With PNOC Scientific Consortium and Day One Biopharmaceuticals
The Pediatric Neuro-Oncology Consortium Foundation, a platinum rated non-profit dedicated to supporting advancements in childhood brain cancer research and clinical trials, announces the FDA approval of Tovorafenib, a significant advancement in the fight against pediatric low-grade glioma brain tumors.
April 24, 2024
·
3 min read
Press Releases
GT Medical Technologies Announces Launch of GammaTile® Center of Excellence Program and First Designation, USC Brain Tumor Center
April 9, 2025
·
3 min read
Press Releases
BrainChild Bio, Inc. to Clinically Advance BCB-276, an Autologous B7-H3 Targeting CAR T-cell Therapy for Incurable Pediatric Brain Tumors
January 7, 2025
·
5 min read
FDA
Day One’s Ojemda Gets FDA Accelerated Approval for Pediatric Brain Tumor
The FDA on Tuesday approved Day One Biopharmaceuticals’ type II RAF inhibitor Ojemda, which is designed to penetrate the blood-brain barrier, for the treatment of relapsed or refractory pediatric low-grade glioma.
April 24, 2024
·
2 min read
·
Tristan Manalac
Press Releases
TippingPoint Biosciences Closes New Funding to Support Drug for Rare Pediatric Brain Tumor
September 4, 2024
·
5 min read
1 of 20,609
Next
